BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND PR, PGR, progesterone receptor AND Prognosis
106 results:

  • 1. Primary pulmonary histiocytic sarcoma with high PD-L1 expression benefited from immunotherapy: A case report and bioinformatic analysis.
    Lin Y; Cao Q; Hong A; Liang X
    Clin Respir J; 2024 Mar; 18(3):e13741. PubMed ID: 38450981
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
    Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
    Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma.
    Hwang JR; Cho YJ; Ryu JY; Choi JY; Choi JJ; Sa JK; Kim HS; Lee JW
    Biomed Pharmacother; 2023 Dec; 168():115792. PubMed ID: 37924789
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A multicenter retrospective analysis of clinical outcomes of intracranial chondrosarcoma in 26 patients.
    Liu H; Li Z; Xue Y; Zhao T; Wu Y
    Sci Rep; 2023 Sep; 13(1):14647. PubMed ID: 37669996
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ZC3H7B-BCOR Fusion High-grade Endometrial Stromal Sarcoma With Morphologic Features of Low-grade Endometrial Stromal Sarcoma. A Case Report and Review of Literature.
    Zhao L; Cheng YW; Policarpio-Nicolas MLC
    Int J Gynecol Pathol; 2023 Nov; 42(6):597-601. PubMed ID: 37562066
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
    Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
    Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Uterin adenosarcoma: French Guidelines of the French Sarcoma Group and the Rare Gynecologic Tumor Group].
    Karabajakian A; Genestie C; Meeus P; Guyon F; Llacer Moscardo C; Croce S; Taieb S; Duffaud F; Pautier P; Ray-Coquard I; Blay JY
    Bull Cancer; 2023; 110(7-8):836-843. PubMed ID: 37202293
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. GATA-3 expression in breast cancer is related to intratumoral M2 macrophage infiltration and tumor differentiation.
    Oda H; Hedayati E; Lindström A; Shabo I
    PLoS One; 2023; 18(3):e0283003. PubMed ID: 36996051
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Peri-osteosarcoma adipose computed tomography attenuation and volume for predicting chemotherapy response in pediatric patients.
    Fu D
    Clin Transl Oncol; 2023 Jun; 25(6):1710-1718. PubMed ID: 36640208
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis.
    Huss A; Klar M; Hasanov MF; Juhasz-Böss I; Bossart M
    Arch Gynecol Obstet; 2023 Mar; 307(3):927-935. PubMed ID: 35780401
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinicopathological characteristics and prognosis of metastatic collecting duct carcinoma.
    Zhou L; Liu Y; Mo J; Cui C; Chi Z; Si L; Kong Y; Yan X; Li S; Wu X; Li J; Xu H; Cao D; Guo J; Sheng X
    Urol Oncol; 2022 Aug; 40(8):385.e1-385.e8. PubMed ID: 35773144
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Alveolar soft tissue sarcoma: a report of 50 cases at a single institution.
    Zhao P; Li H; Ren H
    Acta Chir Belg; 2023 Aug; 123(4):375-383. PubMed ID: 35236247
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Primary low-grade extrauterine endometrial stromal sarcoma: analysis of 10 cases with a review of the literature.
    Wu Y; Li N; Zhang R; Bai P
    World J Surg Oncol; 2022 Jan; 20(1):17. PubMed ID: 35027071
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Clinicopathological features of malignant mixed mesodermal tumor: analysis of 50 cases].
    Ding XH; Ma ZY; Wang YF; Dou FX; Yuan J; Tian X; Liu AJ
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1008-1013. PubMed ID: 34496490
    [No Abstract]    [Full Text] [Related]  

  • 15. Primary undifferentiated pleomorphic sarcoma in oral-maxillary area: retrospective study and molecular analysis.
    You Y; Shi R; Dai M; Du Z; Tian Z; Xu G; Wang L; Wang Y; Xiao M
    Histol Histopathol; 2021 Aug; 36(8):889-898. PubMed ID: 34282850
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. HISTOPATHOLOGICAL, PROLIFERATIVE, APOPTOTIC AND HORMONAL CHARACTERISTICS OF VARIOUS TYPES OF LEIOMYOMAS.
    Kiknadze T; Tevdorashvili G; Muzashvili T; Gachechiladze M; Burkadze G
    Georgian Med News; 2021 Mar; (312):119-125. PubMed ID: 33964839
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Myxoepithelioid tumour with chordoid features: a clinicopathological, immunohistochemical and genetic study of 14 cases of SMARCB1/INI1-deficient soft-tissue neoplasm.
    Kinoshita I; Kohashi K; Yamamoto H; Yamada Y; Inoue T; Higaki K; Teramoto N; Oshiro Y; Nakashima Y; Oda Y
    Histopathology; 2021 Oct; 79(4):629-641. PubMed ID: 33932047
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.
    Mulder EEAP; de Joode K; Litière S; Ten Tije AJ; Suijkerbuijk KPM; Boers-Sonderen MJ; Hospers GAP; de Groot JWB; van den Eertwegh AJM; Aarts MJB; Piersma D; van Rijn RS; Kapiteijn E; Vreugdenhil G; van den Berkmortel FWPJ; Hoop EO; Franken MG; Ryll B; Rutkowski P; Sleijfer S; Haanen JBAG; van der Veldt AAM
    BMC Cancer; 2021 Mar; 21(1):323. PubMed ID: 33765967
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study.
    Le Page C; Almadani N; Turashvili G; Bataillon G; Portelance L; Provencher D; Mes-Masson AM; Gilks B; Hoang L; Rahimi K
    Int J Gynecol Pathol; 2021 Sep; 40(5):487-494. PubMed ID: 33720083
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [The Impact of Induction Treatment Response on the prognosis of Pediatric Core Binding Factor-Acute Myeloid Leukemia Patients].
    Zeng HM; Hu GH; Lu AD; Jia YP; Zuo YX; Wu J; Zhang LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):56-61. PubMed ID: 33554797
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.